AGP Executive Report
Last update: 7 hours agoPediatric Diabetes Care: The FDA approved Afrezza inhaled mealtime insulin for children and teens with type 1 (and type 2) diabetes ages 6+, aiming to reduce needle anxiety and improve school-day dosing. Public Health & Food Safety: Cyclospora “explosive” diarrhea cases are reported across 17 states, with officials still searching for a single source and warning symptoms can be misdiagnosed. Water Safety: Louisiana agencies are tracking swimmer and fish consumption advisories, with multiple waterways under consumption warnings and only a few beaches flagged for bathers. Immigration & Child Welfare: The Trump administration plans a 528-bed Alexandria holding facility for migrant families and unaccompanied children, described as a “staging area,” but advocates worry kids could be held for weeks and oversight may be weak. Local Health Systems: Odyssey House of Louisiana bought the historic Bohn Ford building in New Orleans to expand its addiction treatment and recovery services. Health Costs & Access: A new report highlights how some insurers keep copay assistance meant to lower drug costs, leaving patients to pay more out of pocket. Community Health: New Orleans leadership shifts include Isis Casanova moving to the Health Department to lead health and emergency outreach communications.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
